1. Search Result
Search Result
Results for "

E. coli.

" in MedChemExpress (MCE) Product Catalog:

320

Inhibitors & Agonists

5

Fluorescent Dye

21

Biochemical Assay Reagents

46

Peptides

9

MCE Kits

63

Natural
Products

109

Recombinant Proteins

6

Isotope-Labeled Compounds

1

Antibodies

3

Click Chemistry

3

Oligonucleotides

Cat. No. Product Name Target Research Areas Chemical Structure
  • HY-P2854

    Endogenous Metabolite Metabolic Disease
    Alanine dehydrogenase, expressed in E. coli is a microbial enzyme that catalyzes a reversible conversion of L-alanine to pyruvate .
    Alanine dehydrogenase, expressed in E. coli
  • HY-D1056
    Lipopolysaccharides, from E. coli O55:B5
    Maximum Cited Publications
    265 Publications Verification

    LPS

    Toll-like Receptor (TLR) Inflammation/Immunology Cancer
    Lipopolysaccharides, from E. coli O55:B5 (LPS, from Escherichia coli (O55:B5)) are endotoxins and TLR4 activators extracted from Escherichia coli (E. coli O55:B5) and are classified as S (smooth) type LPS. Lipopolysaccharides, from E. coli O55:B5 possess the typical three-part structure: O-antigen, core oligosaccharide, and lipid A. Lipopolysaccharides, from E. coli O55:B5 activate TLR-4 in immune cells, exhibit high pyrogenicity, and demonstrate dose and serotype specificity. Lipopolysaccharides, from E. coli O55:B5 can be used to induce cellular inflammation and establish animal models related to inflammation .
    Lipopolysaccharides, from E. coli O55:B5
  • HY-157351

    Biochemical Assay Reagents Others
    E.Coli Broth is a selectively concentrated broth that can be used to isolate, detect or culture E. coli.
    E.Coli Broth
  • HY-NP025

    EPEC

    Bacterial Infection
    E.coli Bacterial protein is a native protein that can be isolated from E.coli .
    E.coli Bacterial protein
  • HY-170810

    Bacterial Infection
    E.coli Gyrase B-IN-1 (Compound 10g) is a E.coli Gyrase B inhibitor with antibacterial activities. E.coli Gyrase B-IN-1 has potent inhibitory activity against E. coli, with a MIC value of 0.12 mM. E.coli Gyrase B-IN-1 is promising for research of antimicrobial agents .
    E.coli Gyrase B-IN-1
  • HY-NP020

    E.coli DH-5 alpha protein

    Bacterial Others
    E.coli DH-5 alpha Bacterial protein is a purified native protein from E.coli DH-5 alpha bacterial .
    E.coli DH-5 alpha Bacterial protein
  • HY-E70412

    Endogenous Metabolite Metabolic Disease
    Galactose 1-dehydrogenase, E.coli is a dehydrogenase expressed in E. coli. Galactose 1-dehydrogenase, E.coli catalyzes the oxidation of L-arabinose and D-galactose using NADP +/NAD + as cofactors. Galactose 1-dehydrogenase, E.coli can be used in diagnostic tests to determine total galactose content and can also serve as a biocatalyst for producing galacturonate .
    Galactose 1-dehydrogenase, E.coli
  • HY-P5089

    Biochemical Assay Reagents Infection
    Enterotoxin STp (E. coli) is a heat-stable enterotoxin that can be used in vaccine research .
    Enterotoxin STp (E. coli)
  • HY-D1056A5

    LPS, from Escherichia coli (K-235)

    Toll-like Receptor (TLR) Inflammation/Immunology
    Lipopolysaccharides, from E. coli (Escherichia coli) K-235 are lipopolysaccharide endotoxins and TLR-4 activators derived from E. coli, classified as S-type LPS, which can activate pathogen-associated molecular patterns (PAMP) of the immune system and induce cellular secretion of migrasomes. Lipopolysaccharides, from E. coli K-235 exhibit a typical three-part structure: O-antigen (O-antigen), core oligosaccharide (core oligosaccharide), and lipid A (Lipid A). Lipopolysaccharides, from E. coli K-235 have a mitogenic effect on C57BL/10ScN spleen cells. Additionally, LPS purified using butanol and deoxycholic acid methods stimulates spleen cells in C57BL/10ScCR and C3H/HeJ mice .
    Lipopolysaccharides, from E. coli K-235
  • HY-D1056A4

    LPS, from Escherichia coli (O128:B12)

    Toll-like Receptor (TLR) Inflammation/Immunology
    Lipopolysaccharides, from E. coli O128:B12 (LPS, from Escherichia coli (O128:B12)) are endotoxins and TLR4 activators extracted from Escherichia coli (E. coli O128:B12) and are classified as S (smooth) type LPS. Lipopolysaccharides, from E. coli O128:B12 possess the typical three-part structure: O-antigen, R3-type core oligosaccharide, and lipid A. Lipopolysaccharides, from E. coli O128:B12 activate TLR-4 in immune cells, can be used to construct animal models of neonatal brain inflammation, and may influence preterm birth in neonates .
    Lipopolysaccharides, from E. coli O128:B12
  • HY-D1056A2

    LPS, from Escherichia coli (O127:B8)

    Toll-like Receptor (TLR) Inflammation/Immunology
    Lipopolysaccharides, from E. coli O127:B8 (LPS, from Escherichia coli (O127:B8)) are endotoxins and TLR4 activators extracted from Escherichia coli (E. coli O127:B8) and are classified as S (smooth) type LPS. Lipopolysaccharides, from E. coli O127:B8 possess the typical three-part structure: O-antigen, R3-type core oligosaccharide, and lipid A. Lipopolysaccharides, from E. coli O127:B8 activate TLR-4 in immune cells, can induce inflammatory responses and ileal contractility, and can be used to construct intestinal inflammation models .
    Lipopolysaccharides, from E. coli O127:B8
  • HY-D1056A1

    LPS, from Escherichia coli (O111:B4)

    Toll-like Receptor (TLR) Inflammation/Immunology
    Lipopolysaccharides, from E. coli O111:B4 (LPS, from Escherichia coli (O111:B4)) are endotoxins and TLR4 activators extracted from Escherichia coli (E. coli O111:B4) and are classified as S (smooth) type LPS. Lipopolysaccharides, from E. coli O111:B4 possess the typical three-part structure: O-antigen, R3-type core oligosaccharide, and lipid A. Lipopolysaccharides, from E. coli O111:B4 activate TLR-4 in immune cells and can cause significant gastric diseases. Lipopolysaccharides, from E. coli O111:B4 can be used to induce cellular inflammation and establish animal models related to inflammation .
    Lipopolysaccharides, from E. coli O111:B4
  • HY-P5089A

    Biochemical Assay Reagents Infection
    Enterotoxin STp (E. coli) TFA is a heat-stable enterotoxin that can be used in vaccine research .
    Enterotoxin STp (E. coli) TFA
  • HY-D1056A3

    LPS, from Escherichia coli (O26:B6)

    Toll-like Receptor (TLR) Inflammation/Immunology
    Lipopolysaccharides, from E. coli (Escherichia coli) O26:B6 are lipopolysaccharide endotoxins and TLR-4 activators derived from E. coli, classified as S-type LPS, which can activate pathogen-associated molecular patterns (PAMP) of the immune system and induce cellular secretion of migrasomes. Lipopolysaccharides, from E. coli O26:B6 exhibit a typical three-part structure: O-antigen (O-antigen), core oligosaccharide (core oligosaccharide), and lipid A (Lipid A), and can be recognized by the core-specific monoclonal antibody MAb J8-4C10. Lipopolysaccharides, from E. coli O26:B6 can promote an increase in pro-inflammatory cytokines in plasma, thereby triggering hypothalamic-pituitary-adrenal (HPA) activation and leading to adrenal oxidative damage. The pathogenic effects of Lipopolysaccharides, from E. coli O26:B6 can be blocked by PD149163 (HY-123434) .
    Lipopolysaccharides, from E. coli O26:B6
  • HY-D1056F

    Biotin-LPS, from Escherichia coli (O111:B4)

    Biochemical Assay Reagents Others
    Biotin-Lipopolysaccharide, from E.coli O111:B4 (Biotin-LPS, from Escherichia coli (O111:B4)) is a biotin-conjugated Lipopolysaccharide (LPS) (HY-D1056A1) that can be coupled with streptavidin protein. Biotin-Lipopolysaccharide, from E.coli O111:B4 can be used to identify Lipopolysaccharide ligands. Lipopolysaccharides, from E. coli O111:B4 (LPS, from Escherichia coli (O111:B4)) are endotoxins and TLR4 activators extracted from Escherichia coli (E. coli O111:B4) and are classified as S (smooth) type LPS. Lipopolysaccharides, from E. coli O111:B4 possess the typical three-part structure: O-antigen, R3-type core oligosaccharide, and lipid A. Lipopolysaccharides, from E. coli O111:B4 activate TLR-4 in immune cells and can cause significant gastric diseases. Lipopolysaccharides, from E. coli O111:B4 can also induce M1-type polarization in mouse macrophages .
    Biotin-Lipopolysaccharide, from E.coli O111:B4
  • HY-P2869B

    Endogenous Metabolite Metabolic Disease
    β1-4 Galactosidase, E. coli is a highly specific exoglycosidase that catalyzes the hydrolysis of terminal, non-reducing β1-4 linked galactose residues from oligosaccharides .
    β1-4 Galactosidase, E. coli
  • HY-P2733

    GPO

    Endogenous Metabolite Metabolic Disease
    Glycerol-3-phosphate oxidase, E. coli (GPO) is a key intermediate in glycerol metabolism. Glycerol-3-phosphate oxidase is the skeleton of phospholipids in membrane lipids, and also a substrate in the respiratory chain. Glycerol-3-phosphate oxidase produces electrons through oxidation .
    Glycerol-3-phosphate oxidase, E. coli
  • HY-114737

    Bacterial Infection
    L-573655 is a reversible inhibitor of UDP-3-O-[R-3-hydroxymyristoyl]-GlcNAc deacetylase with an IC50 value of 8.5 μM. L-573655 possesses antibacterial activity against a wild-type strain of E. coli. with MIC values of 200-400 μg/mL .
    L-573655
  • HY-E70284

    Biochemical Assay Reagents Others
    Keratanase II,bacillus circulans,expressed in E.coli has transglycosylation activity. Keratanase II,bacillus circulans,expressed in E.coli efficiently catalyzes the transglycosylation of α(2→3)-sialylated 6,6′-di-sulfo-LacNAc with two kinds of glycosyl acceptors, 6-sulfo-Lewis X and 6,6'-di-sulfo-LacNAc derivatives, providing Sialyl sulfo-hexasaccharide and Sialyl sulfo-pentasaccharide .
    Keratanase II,bacillus circulans,expressed in E.coli
  • HY-P2869

    EC 3.2.1.23; GAL

    Endogenous Metabolite Others
    β-Galactosidase (EC 3.2.1.23) is a glycoside hydrolase that hydrolyzes the β-glycosidic bonds formed between galactose and its organic moieties. In E.coli, the lacZ gene is the structural gene of β-galactosidase, which can be used as part of the induction system lac operon. β-Galactosidase can hydrolyze lactose to form glucose and galactose, and enter glycolysis; it can also catalyze the transgalactosylation of lactose into allolactose; allolactose can be cracked into monosaccharides .
    β-Galactosidase, E. coli
  • HY-P2834

    PGA

    Biochemical Assay Reagents Infection Cancer
    Penicillin amidase (EC 3.5.1.11) (Penicillin acylase) is an enzyme that cleaves the acyl side chains of penicillins. Penicillin amidase can be used for the production of 6-aminopenicillanic acid. Penicillin amidase can also be used in the resolution of racemic mixtures, peptide synthesis, and synthesis of semi-synthetic β-lactam antibiotics .
    Penicillin amidase, E. coli
  • HY-153771

    Bacterial Infection
    Du011 is an E. coli polysaccharide capsule biogenesis inhibitor that targets MprA. Du011 can be used in research against E. coli infection .
    Du011
  • HY-155048

    Bacterial Infection
    BDM91270 (compound 29) is an E. coli AcrAB-TolC efflux pump inhibitor with an EC90 of 0.6 μM for wild-type E. coli AcrB. BDM91270 can be used in the study of Escherichia coli drug resistance .
    BDM91270
  • HY-E70414

    Others Others
    DNase B, Escherichia coli is an enzyme that specializes in the degradation of DNA and can be extracted from E.coli .
    DNase B, Escherichia coli
  • HY-133154
    Carboxyaminoimidazole ribotide
    2 Publications Verification

    CAIR; 4-Carboxy-AIR

    Endogenous Metabolite Infection
    Carboxyaminoimidazole ribotide (CAIR) is a metabolite of E. coli. Carboxyaminoimidazole ribotide can be used to detect distinctive features of E. coli PurE active site and synthesis fungal de novo purine .
    Carboxyaminoimidazole ribotide
  • HY-148197

    Endogenous Metabolite Others
    Glutathionylspermidine is a peptide and a metabolite of E. coli .
    Glutathionylspermidine
  • HY-Y0367
    Maleic Acid
    1 Publications Verification

    Endogenous Metabolite Bacterial Infection
    Maleic Acid is a Glutamate Decarboxylase (GAD) inhibitor of E. coli and L. monocytogenes.
    Maleic Acid
  • HY-144701

    Antibiotic Bacterial Infection Inflammation/Immunology
    SABA1 possesses antibacterial properties against Pseudomonas aeruginosa and Escherichia coli, with an IC50 of 4.0 µM against E. coli ACC .
    SABA1
  • HY-N14359

    Bacterial Infection
    Megovalicin B has the effect against subtilis and E.coli .
    Megovalicin B
  • HY-P1940

    Cyclo(Tyr-Pro)

    Endogenous Metabolite Bacterial Fungal Infection Cancer
    Maculosin (Cyclo (Tyr-Pro)) is a host-specific phytotoxin for spotted knapweed from Alternaria alternata. Maculosin is a quorum-sensing molecule involved in cell-cell communication. Maculosin also acts as a signaling molecule regulating virulence gene expression. Maculosin shows antimicrobial, antifungal, antioxidant and anti-cancer properties .Maculosin (Cyclo (Tyr-Pro)) is a host-specific phytotoxin for spotted knapweed from Alternaria alternata. Maculosin is a quorum-sensing molecule involved in cell-cell communication. Maculosin also acts as a signaling molecule regulating virulence gene expression. Maculosin shows antimicrobial, antifungal, antioxidant and anti-cancer properties .
    Maculosin
  • HY-P1940R

    Endogenous Metabolite Bacterial Fungal Infection Cancer
    Complanatuside (Standard) is the analytical standard of Complanatuside. This product is intended for research and analytical applications. Complanatuside is a flavonoid found in the traditional Chinese medicine Semen Astragali Complanati.
    Maculosin (Standard)
  • HY-E70207

    Bacterial DNA/RNA Synthesis Metabolic Disease
    dam Methyltransferase plays a role in the control of DNA replication in E. coli .
    dam Methyltransferase
  • HY-N14263

    Bacterial Infection
    Kirrothricin has antibacterial action, but no activity to subtilis, E.coli and fungi .
    Kirrothricin
  • HY-162884

    β-glucuronidase Infection
    EcGUS-IN-1 (Compound E-9) is a non-competitive β-glucuronidase inhibitor, with an IC50 of 2.68 μM and a Ki value of 1.64 μM. EcGUS-IN-1 can improve gastrointestinal adverse events (GIAE) caused by Escherichia coli infection by inhibiting E. coli β-glucuronidase activity .
    β-Glucuronidase-IN-4
  • HY-156859

    Bacterial Inflammation/Immunology
    NSC309401 is an inhibitor of E. coli DHFR (IC50: 189 nM, KD: 14.57 nM) .
    NSC309401 dihydrochloride
  • HY-156859A

    Bacterial Infection
    NSC309401 is an inhibitor of E. coli DHFR (IC50: 189 nM, KD: 14.57 nM) .
    NSC309401
  • HY-P5720

    Bacterial Infection
    Peptide 5e is an antimicrobial peptide. Peptide 5e inhibits E. coli, S. aureus, and C. albicans with MIC values of 30, 5, 25 μg/mL respectively .
    Peptide 5e
  • HY-N8300

    Bacterial Infection
    Rupesin E is a natural product that can be isolated from Patrinia rupestris. Rupesin E has significant antibacterial activity against Escherichia coli .
    Rupesin E
  • HY-136861

    Bacterial Infection
    Antibacterial agent 192 is an antibacterial agent that can disrupt iron homeostasis in E. coli .
    Antibacterial agent 192
  • HY-N14132

    DNA/RNA Synthesis Infection
    Cyclothialidine E inhibits escherichia coli DNA helicases with an IC50 of 0.7 μM .
    Cyclothialidine E
  • HY-N2594

    Bacterial Infection
    Isoforsythiaside is an antioxidant and antibacterial phenylethanoid glycoside with MICs of 40.83, 40.83, and 81.66 μg/mL for Escherichia coli(E. coli), Pseudomonas aeruginosa(PAO), and Staphylococcus aureus (SA), respectively .
    Isoforsythiaside
  • HY-144387

    Antibiotic Bacterial Infection Inflammation/Immunology
    ient S. Tm and hyperpermeable Escherichia coli. The potencies against WT strains of E. coli, Acinetobacter baumannii, and Burkholderia cenocepacia are also improved considerably (up to >128-fold) with the outer-membrane permeabi
    Antibacterial agent 71
  • HY-111643

    Bacterial Infection
    6-Amino-5-azacytidine inhibits the growth of bacteria E. coli .
    6-Amino-5-azacytidine
  • HY-139982

    Bacterial Infection
    OX11 is a selective inhibitor of S. pneumoniae, P. aeruginosa, and E. coli bacterial strains .
    OX11
  • HY-P5596

    Bacterial Infection
    Combi-2 is an antimicrobial peptide against S.aureus, S.sanguis and E.coli .
    Combi-2
  • HY-P5566

    Bacterial Infection
    GLK-19 is an antimicrobial peptide, and is active against E. coli (MIC: 10 μM) .
    GLK-19
  • HY-Z15868

    Nucleoside Antimetabolite/Analog Infection
    5-Hydroxycytidine is the RNA modified nucleoside that can be found in the 23S rRNA of bacteria E. coli. 5-Hydroxycytidine modifies at the C2501 site, exhibits a higher modification level in stationary cells. 5-Hydroxycytidine exhibits a higher modification level in radiation resistant Radius than in E. coli .
    5-Hydroxycytidine
  • HY-P5753A

    Bacterial Infection
    JB-95 acetate, a β-hairpin macrocyclic peptide, exhibits potent antimicrobial activity against Escherichia coli. JB-95 acetate can selectively disrupt the outer membrane but not the inner membrane of E. coli .
    JB-95 acetate
  • HY-146400

    Bacterial Infection
    Antibacterial agent 97 (hit compound) is a potent antibacterial agent. Antibacterial agent 97 shows antibacterial activities with MIC of 16 and 16 µg/mL for Escherichia coli (E. coli) and Staphylococcus aureus (S. aureus), respectively .
    Antibacterial agent 97
  • HY-P5753

    Bacterial Infection
    JB-95, a β-hairpin macrocyclic peptide, exhibits potent antimicrobial activity against Escherichia coli. JB-95 can selectively disrupt the outer membrane but not the inner membrane of E. coli .
    JB-95

Inquiry Online

Your information is safe with us. * Required Fields.

Salutation

 

Country or Region *

Applicant Name *

 

Organization Name *

Department *

     

Email Address *

 

Product Name *

Cat. No.

 

Requested quantity *

Phone Number *

     

Remarks

Inquiry Online

Inquiry Information

Product Name:
Cat. No.:
Quantity:
MCE Japan Authorized Agent: